FDA recall D-0169-2021

Hikma Pharmaceuticals USA Inc. · Class II · drug

Product

Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/ml, 2mL Single Dose Vial, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, Vial NDC 0641-0497-17

Reason for recall

Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2ml vial.

Distribution

Distributed Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2020-12-07
Report date
2020-12-23
Termination date
2023-07-18
Voluntary/Mandated
Voluntary: Firm initiated
Location
Cherry Hill, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0169-2021